-
Posted by
Two Blokes Apr 21 -
Filed in
Stock
-
2 views
WASHINGTON, April 21, 2025 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is investigating potential claims on behalf of investors who purchased securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the Company's September 2024 initial public offering (“IPO”). Investors who suffered significant losses are encouraged to contact the firm.
